dengue virus type-3 envelope protein domain iii; expression and immunogenicity
نویسندگان
چکیده
objective(s): production of a recombinant and immunogenic antigen using dengue virus type-3 envelope protein is a key point in dengue vaccine development and diagnostic researches. the goals of this study were providing a recombinant protein from dengue virus type-3 envelope protein and evaluation of its immunogenicity in mice. materials and methods: multiple amino acid sequences of different isolates of dengue virus type-3, corresponding to the envelope protein domain iii, were achieved from genbank. clustal v alignment tool was used to provide a consensus amino acid sequence. nucleotide sequence of the coding gene was optimized using “optimizer”. the origami (de3) strain of escherichia coli was used as the host in order to express the protein. a commercial affinity chromatography method was used to purify the recombinant protein. immunogenicity of the recombinant protein was evaluated in mice using elisa, mtt and cytokine assays. results: a consensus amino acid sequence corresponding to the most important region of dengue virus type-3 envelope protein (domain iii) was provided. a high concentration (≥ 20 mg/l culture medium) of soluble recombinant antigen (ediii3) was achieved. immunized mice developed specific antibody responses against ediii3 protein. the splenocytes from ediii3-immunized mice showed a high proliferation rate in comparison with the negative control. in addition, the concentrations of two measured cytokines (ifn-γ and il-4) were increased markedly in immunized mice. conclusion: the results showed that the expressed recombinant ediii3 protein is an immunogenic antigen and can be applied to induce specific immune responses against dengue virus type-3.
منابع مشابه
Dengue virus type-3 envelope protein domain III; expression and immunogenicity
Objective(s): Production of a recombinant and immunogenic antigen using dengue virus type-3 envelope protein is a key point in dengue vaccine development and diagnostic researches. The goals of this study were providing a recombinant protein from dengue virus type-3 envelope protein and evaluation of its immunogenicity in mice. Materials and Methods: Multiple amino acid sequences of different i...
متن کاملDengue virus type-3 envelope protein domain III; expression and immunogenicity
OBJECTIVES Production of a recombinant and immunogenic antigen using dengue virus type-3 envelope protein is a key point in dengue vaccine development and diagnostic researches. The goals of this study were providing a recombinant protein from dengue virus type-3 envelope protein and evaluation of its immunogenicity in mice. MATERIALS AND METHODS Multiple amino acid sequences of different iso...
متن کاملCharacterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III
Dengue virus (DENV) is a mosquito-borne disease caused by four genetically and serologically related viruses termed DENV-1, -2, -3 and -4. The DENV envelope (E) protein ectodomain can be divided into three structural domains designated ED1, ED2 and ED3. The ED3 domain contains DENV type-specific and DENV complex-reactive antigenic sites. To date, nearly all antigenic studies on the E protein ha...
متن کاملDNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III
Two DNA vaccines were constructed encoding the ectodomain (domains I, II and III) of the DENV2 envelope protein (pE1D2) or only its domain III (pE2D2), fused to the human tissue plasminogen activator signal peptide (t-PA). The expression and secretion of recombinant proteins was confirmed in vitro in BHK cells transfected with the two plasmids, detected by immunofluorescence or immunoprecipitat...
متن کاملCharacterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.
The surface of the mature dengue virus (DENV) particle is covered with 180 envelope (E) proteins arranged as homodimers that lie relatively flat on the virion surface. Each monomer consists of three domains (ED1, ED2, and ED3), of which ED3 contains the critical neutralization determinant(s). In this study, a large panel of DENV-2 recombinant ED3 mutant proteins was used to physically and biolo...
متن کاملNeutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice
Background: Dengue is a global arboviral threat to humans; causing 390 million infections per year. The availability of safe and effective tetravalent dengue vaccine is a global requirement to prevent epidemics, morbidity, and mortality associated with it. Methods: Five experimental groups (6 mice per group) each of 5-week-old BALB/c mice were immunized with vaccine and placebo (empty plasmid) ...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
iranian journal of basic medical sciencesجلد ۱۷، شماره ۱۱، صفحات ۸۳۶-۸۴۳
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023